FBRX

Forte Biosciences Inc.

Price

$76.90

return (12m)

554.47%

p/e

-20.97

p/bv

10.04

DIVIDEND YIELD

0.00%

FBRX price

Forte Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment FBRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

47.36%

3 months

249.55%

1 year

554.47%

2 years

832.12%

5 years

-88.67%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals FBRX

Valuation

P/E

-20.97

Sector -4.38

Industry -4.38

P/BV

10.04

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-66.96

Sector -263.09

Industry -263.09

EV/EBIT

-66.91

Sector -702.90

Industry -702.90

P/EBITDA

-20.51

Sector -4.39

Industry -4.39

P/EBIT

-20.50

Sector -4.73

Industry -4.73

P/Total Assets

8.96

Sector 1.49

Industry 1.49

P/Net Current Assets

10.18

Sector -11.70

Industry -11.70

P/Working Capital

10.09

Sector -3.19

Industry -3.19

EPS

-3.66

Sector -2.14

Industry -2.14

BVPS

7.66

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-47.85%

Sector -65.14%

Industry -65.14%

ROA

-42.74%

Sector -65.53%

Industry -65.53%

ROIC

-2,794.60%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.01

Sector 2.90

Industry 2.90

Net Debt / EBITDA

8.07

Sector -6.07

Industry -6.07

Net Debt / EBIT

8.07

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.08

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.89

Sector 0.41

Industry 0.41

Liabilities/Assets

0.11

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

32.30%

Sector -

Industry -

Fundamentals FBRX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
FBRX Forte Biosciences Inc.	$76.90	545.68%	0.00%	-20.97	10.04	-47.85%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

FBRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Forte Biosciences

Forte Biosciences Inc.

Average Investor10 user rating

4.0 (2 people)

United States

19 years

Founded: 2007

2020

Time since IPO - 6 years

9

Employees

Forte Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.84 billion, with shareholders equity totaling $183.79 million.

The company employs approximately 9 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Forte Biosciences Inc. reported $- in revenue, generating net income of $-87.94 million.

Key financial metrics include a P/E ratio of -20.97, a price-to-book (P/B) ratio of 10.04, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker FBRX.

Market cap

$1.84 billion

Net worth

$183.79 million

$183,790,000.00

Assets

$205.74 million

$205,740,000.00

Total Shares Outstanding

24.00 million

24,000,000

Average Daily Trading Volume

$1.33 million

$1,329,788.00

Sector

Health Care

Industry

Biotechnology

FBRX

FBRX revenue and profits

Financial Results FBRX

DRAG THE FRAME TO SEE MORE DATA

FBRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Forte Biosciences (FBRX) today?

A cotação de Forte Biosciences (FBRX) hoje está em US$ 76.90, com uma variação de 554.47% em relação ao último ano. A cotação de Forte Biosciences (FBRX) iniciou o ano negociando na casa dos US$ 27.27 e hoje está em US$ 76.90. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Forte Biosciences (FBRX) e dados de ações do Ibovespa e mercados internacionais.

Quando Forte Biosciences (FBRX) paga dividendos?

Forte Biosciences (FBRX) não distribuiu dividendos no último ano.

Is Forte Biosciences (FBRX) a good investment?

Atualmente, Forte Biosciences (FBRX) está cotada a US$ 76.90, com um P/L de -20.97, representando um desvio de -689% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 554.47 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 554.47%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Forte Biosciences (FBRX) stock?

Investir em ações de Forte Biosciences (FBRX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Forte Biosciences (FBRX) yield today?

A rentabilidade de Forte Biosciences (FBRX) foi de 47.36% no último mês, 554.47% no último ano e -88.67% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Forte Biosciences (FBRX) hoje, o investimento total seria de US$ 7,690.00, com base na cotação atual de US$ 76.90.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 50,328.74
Em 5 anos: US$ 871.28
Em 10 anos: US$ 7,690.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

FBRX

Forte Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment FBRX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING FBRX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Forte Biosciences

Forte Biosciences Inc.

United States

19 years

2020

9

PROFIT X PRICE FBRX

Financial Results FBRX

FBRX cash flow

Asset, Revenue and Profit Growth - FBRX

FBRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions